FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
Multimedia assets now available: FDA Approves Shire's Xiidra™ (lifitegrast ophthalmic solution) 5% - The Only Treatment Indicated for the Signs and Symptoms of Dry Eye Disease
July 12, 2016
Regulatory Approval - FDA Approves Shire’s Xiidra™ (lifitegrast ophthalmic solution) 5% – The Only Treatment Indicated for the Signs and Symptoms of Dry Eye Disease
July 11, 2016
Shire Receives Extension of Market Authorization in Europe for Revestive? (Teduglutide) for the Treatment of Paediatric Patients with Short Bowel Syndrome (SBS)
July 07, 2016
Shire Announces Top-Line Results for Phase 2 Trial of SHP607 in Extremely Premature Infants
June 30, 2016
Shire Announces Positive Topline Results of SHP465 Efficacy and Safety Study in Adults With ADHD
June 29, 2016
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here